Falcarindiol 法卡林二醇,99.48%

产品编号:Bellancom-N0364| CAS NO:55297-87-5| 分子式:C17H24O2| 分子量:260.37

镰刀菌素二醇是一种口服活性聚乙炔氧脂质,可激活PPARγ并增加细胞中胆固醇转运体ABCA1的表达。镰刀菌素二醇诱导细胞凋亡和自噬。镰刀菌素二醇具有抗炎、抗真菌、抗癌和抗糖尿病特性。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-N0364
3700.00 杭州 北京(现货)
Bellancom-N0364
6000.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Falcarindiol 法卡林二醇

产品介绍 Falcarindiol 是一种具有口服活性的聚乙炔氧脂,可激活 PPARγ 并增加细胞中胆固醇转运蛋白 ABCA1 的表达。Falcarindiol 诱导细胞凋亡和自噬。Falcarindiol 具有抗炎、抗菌、抗癌和抗糖尿病的特性。
生物活性

Falcarindiol, an orally active polyacetylenic oxylipin, activates PPARγ and increases the expression of the cholesterol transporter ABCA1 in cells. Falcarindiol induces apoptosis and autophagy. Falcarindiol has anti-inflammatory, antifungal, anticancer and antidiabetic properties.

体外研究

Falcarindiol (3, 6, 12, 24 µM; for 24 hours) significantly decreases cell viability of MDA-MB-231 and MDA-MB-468 cells. Cell viability of MCF-10A cells is unchanged until the dose of Falcarindiol reaches to 24 uM. Falcarindiol preferentially induces cell death in breast cancer cells.
Falcarindiol (6 uM; for 2 hours) induces autophagy and causes significant level of LC3-I converted to LC3-II in MDA-MB-231, MDA-MB-468 and SKBR3 cells.
Falcarindiol (6 uM; for 2, 4, 8, 24 hours) increases the level of GRP78 in MDA-MB-231 cells in dose- and time-dependent manner.
Falcarindiol (1-20 µM) has no effect on hMSCs and HT-29 cell viability. Falcarindiol with only concentrations above 50 µM exhibits a toxic effect on the cells.
Falcarindiol (5 µM; 10 min, 1 h and 24 h) causes a significant upregulation on PPARγ2 expression at 24 h.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Falcarindiol (7 µg/g; diet) increases ABCA1 expression in neoplastic tissue in five weeks old male rats.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Falcarindiol (7 µg/g; diet) increases ABCA1 expression in neoplastic tissue in five weeks old male rats.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

性状Oil
溶解性数据
In Vitro: 

DMSO : ≥ 33.33 mg/mL (128.01 mM)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.8407 mL 19.2034 mL 38.4069 mL
5 mM 0.7681 mL 3.8407 mL 7.6814 mL
10 mM 0.3841 mL 1.9203 mL 3.8407 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: 1.11 mg/mL (4.26 mM); Suspended solution; Need ultrasonic

    此方案可获得 1.11 mg/mL (4.26 mM) 的均匀悬浊液,悬浊液可用于口服和腹腔注射。

    以 1 mL 工作液为例,取 100 μL 11.1 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液
*以上所有助溶剂都可在 西域 网站选购。
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服